Latest Breaking News On - அறிக்கை நிதி அறிக்கைகள் - Page 1 : comparemela.com

(0) COLLEGE STATION, TX / ACCESSWIRE / March 16, 2021 / Enzolytics, Inc. (OTC Markets ENZC or the Company ) today announced the formalization of corporate legal documents pursuant to Articles of Association forming International Medical Partners ( IMPL ) a Bulgarian Limited Liability Company of which the Company is 50% owner. The agreements are with the Company s partners in IMBL formed with a group of successful Bulgarian businessmen. As a team, the Company with IMPL is moving forward to complete the initial production and certification of its ITV-1 patented therapeutics for treating HIV leading to the planned clinical trials under the European Medicine Agency (the EMA ). A commitment for funding of the cost of clinical trials under EMA guidelines and cost associated with the issuance of an EMA permit are part of the negotiated agreements. Under the Mutual Recognition Agreement (the MRA ) between the EMA and the United States Federal Drug Administration (the FDA ), the Compa

United statesKostenloser wertpapierhandelHarry zhabilovBulgarian limited liability companyArticles of associationWhile enzolytics incTexasam universityBioclonetics immunotherapeutics incDrug administrationResearch centerUnited states federal drug administrationInternational medical partnersEnzolytics incEuropean medicine agencyInstitute for preclinicalMutual recognition agreement